EssilorLuxottica (EL) advances on 2025 dividend settlement and analyst praise
EssilorLuxottica shares are advancing today, driven by the settlement of its 2025 dividend and favourable analyst commentary. The French eyewear giant's stock is up 3.2%, trading at €175.15 on Euronext Paris as of 4 June 2026, following a previous close of €169.75.
The current rise follows the settlement and delivery of new shares for the 2025 dividend, alongside cash payments for those who opted for that modality, on 3 June 2026. This development aligns with recent positive analyst recommendations; Morgan Stanley reiterated its "Overweight" rating on 29 May 2026, while RBC Capital maintained its "Outperform" stance on 28 April 2026.
Today's rebound marks a reversal after several sessions of decline. The stock had fallen 1.4% on 2 June 2026, following news of the company's formalisation of a share dividend option for investors. On the same day, the share price also retreated 2.1% as EssilorLuxottica issued new shares for dividend payments after its annual general meeting decision.
Why EssilorLuxottica's Dividend Resolution Reassured the Market
EssilorLuxottica is a global leader in the eyewear industry. The French company designs, manufactures, and distributes a wide range of products, including corrective lenses, spectacle frames, and sunglasses. With an impressive portfolio of iconic brands like Ray-Ban and Oakley, alongside luxury brand licenses, it serves consumers worldwide through an extensive network of retailers, opticians, and online platforms, addressing both vision correction and sun protection needs.
Today's positive movement in EssilorLuxottica's shares is primarily due to the resolution of its 2025 dividend payment. The market had previously shown apprehension, with the stock experiencing several sessions of decline, including a 1.4% drop on 2 June 2026, stemming from the uncertainty surrounding the possibility of a stock dividend option. However, the finalisation of cash payments and the delivery of new shares for those who opted for them on 3 June 2026 clarified the situation, reassuring investors, alongside favourable analyst ratings.
This decisive resolution has propelled EssilorLuxottica's stock, which is currently up 3.2% and trading at €175.15. This marks a significant rebound from yesterday's close of €169.75, following a period of market unease related to the dividend distribution.
Consider a relay race where the baton is passed between runners. While the baton is in the air, there's a risk it might be dropped, potentially slowing the team. Once the baton is securely in the next runner's hand, the team can regain its full speed. Here, the "baton" was the 2025 dividend, and its secure resolution allowed the market to regain confidence in the stock's trajectory.
EssilorLuxottica
EssilorLuxottica S.A. (EL) is a global leader in ophthalmic products, specialising in the design, manufacture, and distribution of lenses, frames, and sunglasses. Its operations span North America, Europe, Latin America, Asia, Oceania, and Africa, organised across five key segments: Wholesale, Retail, Lenses and Optical Instruments, Equipment, and Sunglasses and Readers. The company's diverse portfolio includes well-known lens brands such as Varilux, Crizal, and Transitions, alongside optical instruments for professionals. Its Equipment division supplies digital surfacing and lens coating machines. The Sunglasses and Readers segment offers a wide array of non-prescription eyewear under various brands, including Foster Grant and Bolon. With a network of 490 prescription laboratories and edging-mounting facilities, EssilorLuxottica was founded in 1849 and is headquartered in Paris, France.